Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Acute 7Leukemia, Myeloid, Accelerated Phase 7Leukemia 7Blast Crisis 6Neoplasms 5Multiple Myeloma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Hodgkin Disease 4Sezary Syndrome 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Large Granular Lymphocytic 3

Interventions

obinutuzumab 2ofatumumab 1milatuzumab 1ibrutinib 1fenebrutinib 1abexinostat 1RO6839921 1KW-2478 1Interleukin-15 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Bronchiolitis Obliterans Syndrome × Dasatinib × Clear all
NCT00103701 2011-04-14

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

Bristol-Myers Squibb

Phase 1 Completed
LymphoidMyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡